Meanwhile, compared to HeLa cells, the lower level of endogenous SOX6 protein contributes to the higher sensitivity of CaSki cells to cisplatin treatment, indicating the possibility that the endogenous SOX6 upregulated by cisplatin may in turn reduce the sensitivity of cervical cancer cells to cisplatin treatment. This evidence concerns the gene SOX6 and cervical carcinoma.